These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24489840)

  • 1. Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.
    Luevano M; Domogala A; Blundell M; Jackson N; Pedroza-Pacheco I; Derniame S; Escobedo-Cousin M; Querol S; Thrasher A; Madrigal A; Saudemont A
    PLoS One; 2014; 9(1):e87086. PubMed ID: 24489840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.
    Spanholtz J; Tordoir M; Eissens D; Preijers F; van der Meer A; Joosten I; Schaap N; de Witte TM; Dolstra H
    PLoS One; 2010 Feb; 5(2):e9221. PubMed ID: 20169160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells differentiated in vitro from cord blood CD34
    Domogala A; Blundell M; Thrasher A; Lowdell MW; Madrigal JA; Saudemont A
    Cytotherapy; 2017 Jun; 19(6):710-720. PubMed ID: 28428057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel myeloid-like NK cell progenitor in human umbilical cord blood.
    Perez SA; Sotiropoulou PA; Gkika DG; Mahaira LG; Niarchos DK; Gritzapis AD; Kavalakis YG; Antsaklis AI; Baxevanis CN; Papamichail M
    Blood; 2003 May; 101(9):3444-50. PubMed ID: 12506032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.
    Cany J; van der Waart AB; Tordoir M; Franssen GM; Hangalapura BN; de Vries J; Boerman O; Schaap N; van der Voort R; Spanholtz J; Dolstra H
    PLoS One; 2013; 8(6):e64384. PubMed ID: 23755121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34(+) cells.
    Domogala A; Madrigal JA; Saudemont A
    Cytotherapy; 2016 Jun; 18(6):754-9. PubMed ID: 27090754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.
    Spanholtz J; Preijers F; Tordoir M; Trilsbeek C; Paardekooper J; de Witte T; Schaap N; Dolstra H
    PLoS One; 2011; 6(6):e20740. PubMed ID: 21698239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence.
    Strowig T; Chijioke O; Carrega P; Arrey F; Meixlsperger S; Rämer PC; Ferlazzo G; Münz C
    Blood; 2010 Nov; 116(20):4158-67. PubMed ID: 20671122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Killer Cells Expanded and Preactivated Exhibit Enhanced Antitumor Activity against Different Tumor Cells in Vitro.
    Biswas BK; Guru SA; Sumi MP; Jamatia E; Gupta RK; Lali P; Konar BC; Saxena A; Mir R
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1595-1605. PubMed ID: 32592353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
    Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells.
    Kao IT; Yao CL; Kong ZL; Wu ML; Chuang TL; Hwang SM
    Stem Cells Dev; 2007 Dec; 16(6):1043-51. PubMed ID: 17999637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34(+) Hematopoietic Stem and Progenitor Cells.
    Roeven MW; Thordardottir S; Kohela A; Maas F; Preijers F; Jansen JH; Blijlevens NM; Cany J; Schaap N; Dolstra H
    Stem Cells Dev; 2015 Dec; 24(24):2886-98. PubMed ID: 26414401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
    Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
    Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
    Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
    Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
    Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
    Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods.
    Dezell SA; Ahn YO; Spanholtz J; Wang H; Weeres M; Jackson S; Cooley S; Dolstra H; Miller JS; Verneris MR
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):536-45. PubMed ID: 22155502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
    Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
    Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
    J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.